Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8225703 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 6 Pages |
Abstract
Bevacizumab in addition to standard pelvic chemoradiotherapy for locally advanced cervical cancer is feasible and safe with respect to the protocol-specified treatment-related SAEs and AEs.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Tracey E. M.D., Kathryn M.S., Janice S. M.D., M.P.H., Kelly M.Sc., Khalid M.D., Brian P. M.D., FRCP (C), William M.D., David K. M.D., Ph.D.,